Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00275834 · ClinicalTrials.gov registry record · NA

Zonisamide for Weight Reduction in Obese Adults

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
225
Enrollment target

NCT00275834 is a NA study that has completed, run by Duke University. The registered enrollment target is 225 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00275834, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
225 participants
Enrollment target

Study Summary

The primary aim of this study is to assess long-term weight loss efficacy of zonisamide relative to placebo in obese patients prescribed a dietary intervention.

Interventions

  • DRUG Zonisamide

Trial Details

FieldValue
Enrollment Target 225 participants
Start Date 2006-01
Est. Completion 2011-09
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT00275834

The ClinicalTrials.gov registry entry for NCT00275834 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Zonisamide is the first listed.

NCT00275834 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00275834 about?

NCT00275834 is a clinical study titled "Zonisamide for Weight Reduction in Obese Adults". The primary aim of this study is to assess long-term weight loss efficacy of zonisamide relative to placebo in obese patients prescribed a dietary intervention.

What is the current status of trial NCT00275834?

This trial is currently completed. It is a NA study. The enrollment target is 225 participants. The study started on 2006-01. Estimated completion is 2011-09.

What interventions are being tested in trial NCT00275834?

The interventions under investigation include: Zonisamide (DRUG).

Who is sponsoring clinical trial NCT00275834?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.